Implementation of a pathological diagnosis and treatment pathway may improve the molecular detection of lung cancer.

ABSTRACT:

Background

The 2018 Guideline from the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) established a benchmark turnaround time (TAT), according to which the results should be available to the treating oncologist within 10 working days. This article focused on the application process of a new protocol for pathological diagnosis and gene testing pathway and a sample collector. We want to solve the problem that there are not enough puncture samples for gene testing, and the benchmark turnaround time of gene detection was long in clinic.

Methods

In this study, we established and validated a new protocol for a pathological diagnosis and treatment pathway that was tested i

SUBMITTER: Shi C 

PROVIDER: S-EPMC8848391 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature